aid: arrivobioventuresllc

name: Arrivobioventuresllc

image: https://arrivobio.com/content/uploads/2025/01/Arrivo_transparent.png

description: Arrivobioventuresllc, operating as Arrivo BioVentures, is a holding company overseeing Sirtsei Pharmaceuticals and Panafina Inc.,
  developing innovative medicines such as SP-624 for major depressive disorder and RABI-767 for severe acute pancreatitis. The company focuses
  on delivering meaningful health outcomes through advanced drug candidates and expanded access programs.

url: https://raw.githubusercontent.com/api-evangelist/arrivobioventuresllc/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-09-26 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-09-26'

modified: '2026-09-26'

tags:
- Biotechnology
- Pharmaceuticals
- Holding Company
- Clinical Trials
- Mental Health

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/arrivobioventuresllc-hosts.yml
- type: Vendors
  url: vendors/arrivobioventuresllc-vendors.yml
- type: Newsroom
  url: https://arrivobio.com/news/
- type: DomainSecurity
  url: security/arrivobioventuresllc-domain-security.yml
- type: Website
  url: https://arrivobio.com

apis:
- name: Arrivo Bio API
  description: API surface discovered via host api.arrivobio.com but no machine-readable spec found.
  humanURL: https://arrivobio.com
  aid: arrivobioventuresllc:arrivo-bio-api

x-coverage:
  state: unreadable
  reason: no-machine-readable-spec
  detail: No OpenAPI, AsyncAPI, GraphQL, or other contract found at api.arrivobio.com despite probing common spec endpoints.
  evidence:
  - url: https://api.arrivobio.com/openapi.json
    status: 0
  checked: 2026-09-26
x-enrichment:
  date: '2026-09-26'
  status: enriched
  artifacts_added: 4
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local